Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes.
Chen Y, Chen J, Zhang S, Zhu D, Deng F, Zuo R, Hu Y, Zhao Y, Duan Y, Lin B, Chen F, Liang Y, Zheng J, Khan BA, Hou K.
Chen Y, et al. Among authors: chen j, chen f.
Front Pharmacol. 2024 Mar 7;15:1370594. doi: 10.3389/fphar.2024.1370594. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38515845
Free PMC article.